Inflation worries remain despite strong earnings as JPMorgan Chase’s Jamie Dimon and David Solomon of Goldman Sachs weigh ...

Evercore ISI raised the firm’s price target on Goldman Sachs (GS) to $660 from $623 and keeps an Outperform rating on the ...

Lenovo Group has entered into a definitive agreement to acquire Tel Aviv-based enterprise storage provider Infinidat, for an undisclosed sum, to expand its storage offerings. The startup provides ...

The bank this week reported that its asset- and wealth-management business posted revenue of US$4.72 billion during the ...

Mexico's economy will stay sluggish this year, a Reuters poll of economists found, as the country braces for a possible ...

Apple stock edges higher after falling Thursday by 4%, the most since August, while Qorvo stock jumps following a report that ...

Anglo-Australian mining giant Rio Tinto , plans to create a standalone lithium division after it closes its $6.7 billion ...

Goldman Sachs updates its view on Tesla FSD, says 'Tesla's Robotaxi business to begin commercial operations in 2H 2026' with ...

While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.

Shares had closed at a new record on Thursday ahead of the Switch 2 announcement, building on the 26% gain last year amid growing expectations for the new hardware. On Friday, the stock fell as much ...